Name: Latest research reports of Laurus Labs Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

1082.4500 25.00 (2.36%)

NSE Apr 08, 2026 15:31 PM

96.45% Gain from 52W Low

Volume: 1.6M

Laurus Labs Ltd.

24 Oct 2025

1082.45

2.36%

Laurus Labs (HOLD): Operating leverage to emerge slower

Hold: Laurus Labs Ltd.

Target

BOB Capital Markets Ltd.

Sales /EBITDA/PAT surpassed our estimates by 18%, 28% and 75%; exceeded consensus by 11%. 31% and 74% respectively

Laurus Labs Ltd. has an average target of 1035.40 from 5 brokers.